Kent Meningitis Outbreak: Students Queue for Vaccines Amid Health Crisis
Students have been seen queuing to receive vaccines and antibiotics at the University of Kent campus in Canterbury, as a deadly meningitis outbreak fuels concerns about the disease's spread. The scenes, reminiscent of the Covid-19 pandemic, involve people wearing masks and waiting in lines, but meningitis is a very different health threat. This article explores how the outbreak has unfolded, the nature of the disease, and the public health response.
What Is Meningitis?
Meningitis is a potentially lethal but uncommon disease caused by viruses and bacteria that trigger inflammation of the meninges, the protective linings covering the brain. The Kent outbreak is driven by meningococcal bacteria, specifically the MenB strain, which are found in the nose and throat of about 10% of the population. These bacteria have lived in humans for centuries, giving public health officials extensive experience in managing outbreaks. "With this particular organism, we’ve got several hundred years of history now, and we can absolutely predict what factors are likely to have played into the outbreak," said Prof Sir Andrew Pollard at the University of Oxford, director of the Oxford Vaccine Group. In contrast, Covid-19 involved a new, highly transmissible airborne virus with no prior immunity.
Who Is at Risk?
Meningitis is more common in babies, teenagers, and young adults. Babies are vulnerable due to underdeveloped immune systems, while teenagers and young people face higher exposure from living conditions and social behavior. In student populations, about 25% carry the bacteria, potentially passing them on through close contact.
How Does Bacterial Meningitis Spread?
Meningococcal bacteria spread through close and prolonged contact, such as living in shared accommodations, kissing, or sharing drinks or vapes. Unlike Covid-19, which spreads easily through airborne particles, meningitis bacteria do not survive well outside saliva droplets and quickly sink if coughed out. "It’s much harder to pick up, because it’s just not around in the environment in the same way," said Dr Eliza Gil, a clinical lecturer at the London School of Hygiene & Tropical Medicine.
How Fast Does It Spread?
While Covid-19 had an R value around three early in the pandemic, meningitis spreads far less effectively. Too few cases exist to calculate a reliable R value for the Kent outbreak, but the widespread offering of antibiotics and vaccinations is expected to help contain it.
How Common Is Meningitis?
Meningitis cases have declined since the 1990s, when England saw over 2,000 cases annually, largely due to vaccines like the MenC jab introduced in 1999. The NHS now offers MenB vaccines for babies, but protection wanes by adolescence. Cases plummeted during the pandemic but rebounded to 378 in 2024-25, similar to other infections like influenza and whooping cough. Public health officials in England typically see about one case per day on average.
Why Do Some People Get Severely Ill?
Severe illness occurs when bacteria enter the bloodstream and reach the brain, with factors like strain type and individual immunity playing key roles. "We often see cases in the first year or two after people go to university," Pollard noted, explaining that strains mix in central places, leading to disease in susceptible individuals.
What Sparked the Kent Outbreak?
The outbreak has been traced to Club Chemistry in Canterbury, a nightclub setting that has historically facilitated infection spread. A study found that activities like going to pubs and clubs, kissing, and smoking raise meningococcal infection risk fourfold. Gil suspects a superspreader triggered the outbreak, with factors like recent respiratory infections or vaping increasing susceptibility. As of Friday, 18 cases were confirmed, 11 under investigation, and two deaths reported.
How Is the Outbreak Being Contained?
The public health response is well-rehearsed: meningitis patients are hospitalized, while at-risk individuals, including nightclub attendees, receive antibiotics and the Bexsero MenB vaccine. Antibiotics aim to kill bacteria before severe illness, and the vaccine provides protection over five weeks, though it does not prevent nasal or throat infection spread.
